Mario Álvarez‐Maestro

Author

Also Known As

Andrey Semenov, Emanuele Montanari, Emilio Ríos González, M Alvarez Maestro, M. Alvarez Maestro, M. Alvarez-Maestro, M. Maestro, M. Álvarez Maestro, M. Álvarez-Maestro, M. Álvarez–Maestro

214

Publications

1.6K

Citations

H-Index

Concepts

All Affiliations

Hospital Universitario La Paz Medical University of Vienna European Institute of Oncology Vita-Salute San Raffaele University Wroclaw Medical University

MÁ

About

Mario Álvarez‐Maestro is an author at Hospital Universitario La Paz specializing in medicine, urology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	14	449
2	Public Health	4	4	94
3	Arts	1	1	17
4	Health Sciences	1	1	63
5	Biostatistics	1	1	27

Mario Álvarez‐Maestro

Publications

860

Citations

H-Index

Page 1

	Year	Citations
Analysis of radical cystectomy and urinary diversion complications with the Clavien classification system in an Italian real life cohort Cosimo De Nunzio, Luca Cindolo, Costantino Leonardo, European Journal of Surgical Oncology LaparoscopyUrologyRadical CystectomyPelvic Reconstructive SurgeryUrinary Diversion Complications	2013	84
Validation of a Novel, Sensitive, and Specific Urine-Based Test for Recurrence Surveillance of Patients With Non-Muscle-Invasive Bladder Cancer in a Comprehensive Multicenter Study Rui Batısta, João Vinagre, Hugo Prazeres, Frontiers in Genetics	2019	78
DUTRENEO Trial: A randomized phase II trial of DUrvalumab and TREmelimumab versus chemotherapy as a NEOadjuvant approach to muscle-invasive urothelial bladder cancer (MIBC) patients (pts) prospectively selected by an interferon (INF)-gamma immune signature. Enrique Grande, Félix Guerrero‐Ramos, Javier Puente, Journal of Clinical Oncology Radical CystectomyImmunologyPathologyImmunotherapeuticsImmunotherapy	2020	63
The use of mannitol in partial and live donor nephrectomy: an international survey Marco Cosentino, Alberto Breda, Francesco Sanguedolce, World Journal of Urology Transplantation SurgeryLive Donor NephrectomyUrologyTransplant SurgerySurgery	2012	47
NKG2D is a Key Receptor for Recognition of Bladder Cancer Cells by IL-2-Activated NK Cells and BCG Promotes NK Cell Activation Eva M. García‐Cuesta, Sheila López‐Cobo, Mario Álvarez‐Maestro, Frontiers in Immunology Cancer ImmunosurveillanceIl-2-activated Nk CellsMedicineImmunologyImmunoediting	2015	44
Characterization of a human anti-tumoral NK cell population expanded after BCG treatment of leukocytes Eva M. García‐Cuesta, Gloria Esteso, Omodele Ashiru, OncoImmunology	2017	39
Adherence to EAU guidelines on penile cancer translates into better outcomes: a multicenter international study Luca Cindolo, Philippe E. Spiess, Maida Bada, World Journal of Urology UrologyClinical EffectivenessMedicineCancer ManagementEau Guidelines	2018	38
Impact of COVID-19 on medical education: introducing homo digitalis Stavros Gravas, Mumtaz Ahmad, Andrés Hernández-Porras, World Journal of Urology	2020	35
Development Methodology of the Novel Endoscopic Stone Treatment Step 1 Training/Assessment Curriculum: An International Collaborative Work by European Association of Urology Sections Domenico Veneziano, Kamran Ahmed, Ben Van Cleynenbreugel, Journal of Endourology	2017	30
Current treatments for BCG failure in non-muscle invasive bladder cancer (NMIBC) Mario Álvarez‐Maestro, Félix Guerrero‐Ramos, Óscar Rodríguez-Faba, Actas Urológicas Españolas (English Edition) UrologyVoiding DysfunctionCurrent TreatmentsGenitourinary CancerMedicine	2021	27

Page 1